Your browser doesn't support javascript.
loading
First use of the anti-VWF nanobody caplacizumab to treat iTTP in pregnancy.
Kühne, Lucas; Völker, Linus A; Hagmann, Henning; Hägele, Holger; Osterholt, Thomas; Eichenauer, Dennis A; Thomas, Andreas; Breuer, Johanna; Grüttner, Berthold; Gottschalk, Ingo; Kann, Martin; Benzing, Thomas; Thevis, Mario; Müller, Annette M; Brinkkoetter, Paul T.
Afiliación
  • Kühne L; Department II of Internal Medicine and Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Völker LA; Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases (CECAD), Cologne, Germany.
  • Hagmann H; Department II of Internal Medicine and Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Hägele H; Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases (CECAD), Cologne, Germany.
  • Osterholt T; Department II of Internal Medicine and Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Eichenauer DA; Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases (CECAD), Cologne, Germany.
  • Thomas A; Department II of Internal Medicine and Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Breuer J; Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases (CECAD), Cologne, Germany.
  • Grüttner B; Department II of Internal Medicine and Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Gottschalk I; Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases (CECAD), Cologne, Germany.
  • Kann M; Department I of Internal Medicine, Center for Integrated Oncology, Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany.
  • Benzing T; Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.
  • Thevis M; Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.
  • Müller AM; Department of Obstetrics and Gynecology, University Hospital of Cologne, Cologne, Germany.
  • Brinkkoetter PT; Department of Obstetrics and Gynecology, University Hospital of Cologne, Cologne, Germany.
Br J Haematol ; 196(3): e30-e33, 2022 02.
Article en En | MEDLINE | ID: mdl-34585743
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Complicaciones Hematológicas del Embarazo / Púrpura Trombocitopénica Trombótica / Factor de von Willebrand / Anticuerpos de Dominio Único Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Complicaciones Hematológicas del Embarazo / Púrpura Trombocitopénica Trombótica / Factor de von Willebrand / Anticuerpos de Dominio Único Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Alemania